Glycomimetics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Glycomimetics Inc
TickerCBIO
CIK #0001253689
CUSIPG2545C104
SectorLife Sciences - Pharmaceutical Preparations
Address401 Professional Drive, Suite 250, Gaithersburg, MD 20879
Source [EDGAR]
CIK Filing 2011 - 2025
[0001253689] 10-K
[0001253689] 10-Q
[0001253689] 3
[0001253689] 4
[0001253689] 5
[0001253689] 8-K
[0001253689] SC 13D
[0001253689] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
1Globe Capital LLC Crescent Biopharma Inc [2025-08-20] 0.0
FMR LLC Crescent Biopharma Inc [2025-07-08] 0.0
Venrock Healthcare Capital Partners III LP Glycomimetics Inc [2025-06-23] 0.0
Fairmount Funds Management LLC Glycomimetics Inc [2025-06-23] 0.0
Logos Global Management LP Glycomimetics Inc [2024-11-27] 7.8
RA Capital Management LP Glycomimetics Inc [2024-11-06] 0.9
Adage Capital Management LP Glycomimetics Inc [2024-11-04] 7.9
Weinstein Benjamin Glycomimetics Inc [2024-08-14] 0.0
Artal International SCA Glycomimetics Inc [2023-02-13] 12.5
Vanguard Group Inc Glycomimetics Inc [2021-02-10] 5.37
EcoR1 Capital LLC Glycomimetics Inc [2020-07-20] 6.7
Camber Capital Management LP Glycomimetics Inc [2019-08-15] 2013.0
Biotechnology Value Fund L P Glycomimetics Inc [2019-08-15] 5.1
Invesco Ltd Glycomimetics Inc [2019-06-10] 11.0
Price T Rowe Associates Inc /MD/ Glycomimetics Inc [2019-02-14] 8.0
BlackRock Inc Glycomimetics Inc [2019-02-08] 6.6
OppenheimerFunds Inc Glycomimetics Inc [2018-09-06] 10.28
FMR LLC Glycomimetics Inc [2018-02-13] 0.0
Biotechnology Value Fund L P Glycomimetics Inc [2016-06-27] 4.7
Franklin Resources Inc Glycomimetics Inc [2016-02-05] 5.3
Wellington Management Co LLP Glycomimetics Inc [2014-02-10] 10.79
New Enterprise Associates 10 L P Glycomimetics Inc [2014-01-23] 50.3
Form 3/4/5 Filer 2011 - 2025
Crescent Biopharma Inc
Pinkas Jan
Bispham Barbara Harlin
Im Ellie Eunkyung
Lubner David Charles
Balcom Alexandra
Violin Jonathan
Fairmount Funds Management LLC
Harwin Peter Evan
Kiselak Tomas
Fairmount Healthcare Fund II L.P.
Brumm Joshua T
McNeill Jonathan
Scalzo Richard William
Doughty Christopher Grant
Lynch Ryan
Moran Susan
BVF II GP LLC
BVF Partners OS Ltd.
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
Lampert Mark N
BVF I GP LLC
BVF Partners L P/IL
Biotechnology Value Trading Fund OS LP
BVF Inc/IL
BVF GP Holdings LLC
Debbane Raymond
Invus Public Equities, L.P.
Invus Public Equities Advisors, LLC
Invus Global Management, LLC
Siren, L.L.C.
Rock Edwin
Hahn Brian M.
King Rachel K.
Koenig Scott
Goldberg Mark Alan
Pearson Timothy R
Andrews Patricia S
Jackson Scott Thomas
Junius Daniel M
Johnson Bruce S
Semerjian Harout
Rath Chinmaya
Artal International S.C.A.
Artal Group S.A.
Artal International Management S.A.
Wittouck Amaury
Stichting Administratiekantoor Westend
Westend S.A.
Sandell Scott D
Girard Armand
Magnani John L.
Feldman Eric Jay
Thackray Helen M.
Barrett M James
NEA Partners 10 L P
New Enterprise Associates 10 L P
Barris Peter J
Baldwin John J.
Top Franklin H Jr
Henos Michael A
Kolluri Krishna Kittu
Weller Harry R
Kerins Patrick J
Baskett Forest
NEA 13 GP, Ltd
NEA Partners 13, Limited Partnership
Mott David M
Drant Ryan D
New Enterprise Associates 13 LP
Viswanathan Ravi
Gust William M.
Sanofi
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2025-06-30] DFND 1,414,190 1,414,190
Fairmount Funds Management LLC [2025-06-30] SOLE 1,387,866 1,387,866
VR Adviser LLC [2025-06-30] SOLE 1,387,864 1,387,864
BVF Inc/IL [2025-06-30] DFND 0 1,387,863
Paradigm Biocapital Advisors LP [2025-06-30] SOLE 642,721 642,721
Logos Global Management LP [2025-06-30] SOLE 553,686 553,686
Boxer Capital Management LLC [2025-06-30] SOLE 0 453,686
Deep Track Capital LP [2025-06-30] SOLE 453,686 453,686
Perceptive Advisors LLC [2025-06-30] SOLE 453,686 453,686
Commodore Capital LP [2025-06-30] SOLE 453,686 453,686
Frazier Life Sciences Management LP [2025-06-30] SOLE 453,685 453,685
Soleus Capital Management LP [2025-06-30] SOLE 400,000 400,000
Driehaus Capital Management LLC [2025-06-30] SOLE 302,457 302,457
Affinity Asset Advisors LLC [2025-06-30] SOLE 280,031 280,031
Braidwell LP [2025-06-30] SOLE 261,504 261,504
Wellington Management Group LLP [2025-06-30] DFND 0 179,886
Adage Capital Partners GP LLC [2025-06-30] SOLE 100,912 100,912
Blackstone Inc. [2025-06-30] OTR 0 75,614
Tang Capital Management LLC [2025-06-30] OTR 0 50,152
Jefferies Financial Group Inc. [2025-06-30] DFND 27,096 27,096
Morgan Stanley [2025-06-30] DFND 15,387 15,394
Bank of America Corp /DE/ [2025-06-30] DFND 0 9,231
BlackRock, Inc. [2025-06-30] SOLE 5,973 6,051
Barclays PLC [2025-06-30] SOLE 286 286
UBS Group AG [2025-06-30] DFND 223 223
Group One Trading LLC [2025-06-30] SOLE 162 162
SBI Securities Co., Ltd. [2025-06-30] DFND 68 68
Raymond James Financial Inc [2025-06-30] DFND 0 50
Royal Bank of Canada [2025-06-30] DFND 20 20
BNP Paribas Financial Markets [2025-06-30] DFND 0 4
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com